UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
| ||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AMARIN CORP PLC | SPONS ADR NEW | 023111206 | 12,052,552 | 24,850,623 | SH | SOLE | 24,850,623 | 0 | 0 | ||
| CYTOKINETICS INC | COM NEW | 23282W605 | 39,221,905 | 833,799 | SH | SOLE | 833,799 | 0 | 0 | ||
| GILEAD SCIENCES INC | COM | 375558103 | 24,208,330 | 262,080 | SH | SOLE | 262,080 | 0 | 0 | ||
| INNOVIVA INC | COM | 45781M101 | 126,255,950 | 7,277,000 | SH | SOLE | 7,277,000 | 0 | 0 | ||
| IRONWOOD PHARMACEUTICALS INC | COM CL A | 46333X108 | 72,607,700 | 16,390,000 | SH | SOLE | 16,390,000 | 0 | 0 | ||
| LANTHEUS HLDGS INC | COM | 516544103 | 5,635,980 | 63,000 | SH | SOLE | 63,000 | 0 | 0 | ||
| NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 42,194,334 | 309,116 | SH | SOLE | 309,116 | 0 | 0 | ||
| VOR BIOPHARMA INC | COM | 929033108 | 685,980 | 618,000 | SH | SOLE | 618,000 | 0 | 0 | ||